The market just handed patient investors a gift -- three high-growth companies solving real problems, now trading at 30-day ...

Anthropic believes AI models will increasingly reach into the physical world. To understand where things are headed, it asked ...

Google Maps is much smarter now, thanks to Gemini AI, but it hasn't rolled out to everyone yet. No matter. I like the free Gemini app. It's map savvy.

Stereotaxis announced today that it received FDA 510(k) clearance for its next-generation GenesisX surgical robot.

Discover how Serve Robotics’ rapid robot deployment, AI integration, and partnerships drive projected 10x revenue growth in 2026.

Q3 2025 Earnings Call Transcript November 14, 2025 Operator: Good morning, ladies and gentlemen, and welcome to the Nauticus Robotics 2025 Q3 Earnings Call. [Operator Instructions] This call is being ...

Vicarious Surgical (NYSE:RBOT) today announced third-quarter financial results that included another delay in its surgical ...

Artificial intelligence, particularly in sensor fusion, is now rewriting autonomy’s playbook—and serving as a powerful ...

In a historic leap for neurovascular medicine, XCath’s EVR robotic system has successfully treated three patients with ...

Read here for latest insights on Serve Robotics (SERV) stock: evaluate its growth with UberEats, financial risks, and market ...

The real AI race isn’t just about smarter code — it’s about who will shape the future of power, machines and, ultimately, ...

Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results ...